GlassScriptPhysician profile
Gloria G Box
NPI 1386628246
$3,011.42
in general payments reported to CMS, 2019-2025
18 companies · $485 in 2025
The $485 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $892 · 2020: $575 · 2021: $193 · 2022: $351 · 2023: $451 · 2024: $64.20 · 2025: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $873 · Travel and Lodging: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $872.68 |
| Travel and Lodging | $127.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,237.94 | 2019-2020 | |
| Abbvie INC. | $389.55 | 2021-2025 | Dalvance |
| Pacira Pharmaceuticals Incorporated | $314.03 | 2023 | Iovera, Exparel, Zilretta |
| Orthofix Medical, INC. | $309.30 | 2019-2025 | Physio-Stim |
| Baudax Bio INC. | $209.34 | 2020-2022 | |
| Stryker Corporation | $193.41 | 2019-2022 | |
| Organogenesis INC. | $66.19 | 2025 | Cygnus Dual, Via Matrix |
| Kerecis Limited | $60.29 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Convatec INC. | $41.76 | 2020-2023 | |
| Amgen INC. | $35.59 | 2019-2020 | |
| Abbott Laboratories | $28.57 | 2025 | Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.82 | 2023-2024 | Xifaxan |
| Bioventus LLC | $24.85 | 2025 | Durolane |
| Ethicon US, LLC | $17.54 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.06 | 2023 | Seglentis |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $14.94 | 2022 | |
| Reprise Biomedical, INC. | $14.11 | 2025 | Miro 3d |
| Allergan, INC. | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gloria Box listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.